CancerCare Manitoba

Winnipeg, Manitoba

We've found

1 trials

at this facility

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Winnipeg,

Use our guide to learn which trials are right for you!